Literature DB >> 11397260

A retrospective-cohort study on the development of cataracts in dogs with diabetes mellitus: 200 cases.

S. Beam1, M.T. Correa, M.G. Davidson.   

Abstract

The objective of the study was to determine the incidence and estimated median time to cataract formation in dogs with diabetes mellitus. The animals studied were 200 dogs with diabetes mellitus which were referred to a university teaching hospital between 1985 and 1995. Medical records from dogs with a diagnosis of diabetes mellitus were reviewed and, where necessary, further follow-up information was gathered from the referring veterinarian. Incidence rate and median time to diabetic cataract formation was calculated using survival-analysis techniques in a retrospective cohort study design. Among the 200 dogs in the study population, 23 had cataracts at the time of diabetes diagnosis that were presumed to be related to other disease processes. Of the remaining 177 dogs, 132 had documented cataract development with features suggestive as being secondary to diabetes. Twenty-three dogs did not have obvious cataracts at the time of their last examination while 22 dogs did not have cataracts at the time they were lost to follow-up. These 55 cases contributed to the statistical models as noncases of cataracts until the last date for which an examination was available. Half of the population had developed cataracts by the 170th day postdiagnosis of diabetes mellitus, while 75% and 80% of the population developed cataracts by 370 days and 470 days, respectively. The results of this study suggest that the majority of dogs with diabetes will develop cataracts within 5-6 months from the time of diagnosis of the disease, and that approximately 80% of dogs will develop cataracts within 16 months of diagnosis.

Entities:  

Year:  1999        PMID: 11397260     DOI: 10.1046/j.1463-5224.1999.00073.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  7 in total

1.  Topical KINOSTAT™ ameliorates the clinical development and progression of cataracts in dogs with diabetes mellitus.

Authors:  Peter F Kador; Terah R Webb; Dineli Bras; Kerry Ketring; Milton Wyman
Journal:  Vet Ophthalmol       Date:  2010-11       Impact factor: 1.644

2.  Evaluation of advanced glycation end-products in diabetic and inherited canine cataracts.

Authors:  I Dineli Bras; Carmen M H Colitz; Donna F Kusewitt; Heather Chandler; Ping Lu; Anne J Gemensky-Metzler; David A Wilkie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

Review 3.  Monitoring methods for dogs and cats with diabetes mellitus.

Authors:  Audrey K Cook
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

4.  Photoperiodic regime influences onset of lens opacities in a non-human primate.

Authors:  Marko Dubicanac; Julia Strueve; Nadine Mestre-Frances; Jean-Michel Verdier; Elke Zimmermann; Marine Joly
Journal:  PeerJ       Date:  2017-05-04       Impact factor: 2.984

5.  Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.

Authors:  Maria Luisa Jaén; Laia Vilà; Ivet Elias; Veronica Jimenez; Jordi Rodó; Luca Maggioni; Rafael Ruiz-de Gopegui; Miguel Garcia; Sergio Muñoz; David Callejas; Eduard Ayuso; Tura Ferré; Iris Grifoll; Anna Andaluz; Jesus Ruberte; Virginia Haurigot; Fatima Bosch
Journal:  Mol Ther Methods Clin Dev       Date:  2017-04-05       Impact factor: 6.698

6.  Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice.

Authors:  Jennifer Ann Cartwright; Malcolm Cobb; Mark D Dunning
Journal:  Vet Rec Open       Date:  2019-05-24

7.  Effect of Oral Alpha Lipoic Acid in Preventing the Genesis of Canine Diabetic Cataract: A Preliminary Study.

Authors:  David L Williams
Journal:  Vet Sci       Date:  2017-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.